These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Malignant transformation of oral verrucous leukoplakia: a clinicopathologic study of 53 cases. Liu W; Shen XM; Liu Y; Li J; Zhou ZT; Wang LZ J Oral Pathol Med; 2011 Apr; 40(4):312-6. PubMed ID: 21342275 [TBL] [Abstract][Full Text] [Related]
25. Malignant transformation of oral proliferative verrucous leukoplakia: a series of 48 patients with suggestions for management. Favia G; Capodiferro S; Limongelli L; Tempesta A; Maiorano E Int J Oral Maxillofac Surg; 2021 Jan; 50(1):14-20. PubMed ID: 32586723 [TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic analysis of verrucous hyperplasia, verrucous carcinoma and squamous cell carcinoma as part of the clinicopathologic spectrum of oral proliferative verrucous leukoplakia: A literature review and analysis. Akrish S; Eskander-Hashoul L; Rachmiel A; Ben-Izhak O Pathol Res Pract; 2019 Dec; 215(12):152670. PubMed ID: 31630872 [TBL] [Abstract][Full Text] [Related]
32. Current management strategies for verrucous hyperkeratosis and verrucous carcinoma. Sciubba JJ; Helman JI Oral Maxillofac Surg Clin North Am; 2013 Feb; 25(1):77-82, vi. PubMed ID: 23399397 [TBL] [Abstract][Full Text] [Related]
33. Proliferative multifocal leukoplakia better name that proliferative verrucous leukoplakia. Aguirre-Urizar JM World J Surg Oncol; 2011 Oct; 9():122. PubMed ID: 21985464 [TBL] [Abstract][Full Text] [Related]
34. Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: a pre-cancer niche for oral squamous cell carcinoma development. Llorens C; Soriano B; Trilla-Fuertes L; Bagan L; Ramos-Ruiz R; Gamez-Pozo A; Peña C; Bagan JV Clin Oral Investig; 2021 May; 25(5):2645-2657. PubMed ID: 32918120 [TBL] [Abstract][Full Text] [Related]
35. Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners. Staines K; Rogers H Br Dent J; 2017 Dec; 223(9):655-661. PubMed ID: 29097794 [TBL] [Abstract][Full Text] [Related]
36. Optimal Management of Proliferative Verrucous Leukoplakia: A Systematic Review of the Literature. Abadie WM; Partington EJ; Fowler CB; Schmalbach CE Otolaryngol Head Neck Surg; 2015 Oct; 153(4):504-11. PubMed ID: 26044786 [TBL] [Abstract][Full Text] [Related]
37. Exophytic verrucous hyperplasia as a clinical terminology includes verrucous hyperplasia with or without epithelial dysplasia in histology. Liu W; Zhu L; Xu L; Wu L Oral Oncol; 2021 Nov; 122():105571. PubMed ID: 34666228 [No Abstract] [Full Text] [Related]
38. Proliferative verrucous leukoplakia and field cancerization: report of a case. Feller L; Wood NH; Raubenheimer EJ J Int Acad Periodontol; 2006 Apr; 8(2):67-70. PubMed ID: 16623182 [TBL] [Abstract][Full Text] [Related]
39. High incidence of DNA ploidy abnormalities and increased Mcm2 expression may predict malignant change in oral proliferative verrucous leukoplakia. Gouvêa AF; Santos Silva AR; Speight PM; Hunter K; Carlos R; Vargas PA; de Almeida OP; Lopes MA Histopathology; 2013 Mar; 62(4):551-62. PubMed ID: 23347057 [TBL] [Abstract][Full Text] [Related]
40. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: a series of 55 cases. Bagan JV; Jiménez-Soriano Y; Diaz-Fernandez JM; Murillo-Cortés J; Sanchis-Bielsa JM; Poveda-Roda R; Bagan L Oral Oncol; 2011 Aug; 47(8):732-5. PubMed ID: 21683646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]